相关实验视频

Updated: Jul 6, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

基于血液的多种癌症检测:一个最先进的更新

Maria Farooq¹, Elyse Leevan², Jibran Ahmed³

¹Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Current problems in cancer

|January 5, 2024

概括

早期发现癌症至关重要. 多种癌症检测 (MCD) 血液测试显示出希望,但需要更多的临床数据来指导它们在一般人口查中的使用.

科学领域:

在瘤学瘤学.
生物标志物发现发现
临床试验设计临床试验设计

背景情况:

国家癌症计划强调早期癌症检测.
分析循环瘤DNA (ctDNA) 的多种癌症检测 (MCD) 试验是新兴的工具.
目前,一般人群查的前性临床数据有限.

研究的目的:

审查MCD测定背后的技术.
讨论MCD试验的性能标准.
概述正在进行的临床研究和NCI倡议,以评估MCD测定.

主要方法:

审查当前的MCD技术和临床发展.
对选试验的性能要求的分析.
总结正在进行的临床试验和NCI的基础设施开发.

主要成果:

目前正在开发各种MCD技术.
适当的测定性能对于临床实用性至关重要.
目前正在进行临床研究,以评估MCD测试的有效性.
NCI正在建立基础设施,以支持评估.

结论:

MCD测定提供了早期,非侵入性癌症检测的潜力.
进一步的前性临床验证对于广泛的查至关重要.
为了应对科学和后勤方面的挑战,需要标准化的评估框架.

关键词:

癌症查癌症查早期检测早期检测非侵袭性癌症检测是一种非侵袭性癌症检测.

更多相关视频

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...